Literature DB >> 22210207

Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model.

Sara Schumann1, Carl Alpert, Wolfram Engst, Gunnar Loh, Michael Blaut.   

Abstract

To identify Escherichia coli proteins involved in adaptation to intestinal inflammation, mice were monoassociated with the colitogenic E. coli strain UNC or with the probiotic E. coli strain Nissle. Intestinal inflammation was induced by treating the mice with 3.5% dextran sodium sulfate (DSS). Differentially expressed proteins in E. coli strains collected from cecal contents were identified by 2-dimensional difference gel electrophoresis. In both strains, acute inflammation led to the downregulation of pathways involved in carbohydrate breakdown and energy generation. Accordingly, DSS-treated mice had lower concentrations of bacterial fermentation products in their cecal contents than control mice. Differentially expressed proteins also included the Fe-S cluster repair protein NfuA, the tryptophanase TnaA, and the uncharacterized protein YggE. NfuA expression was 3-fold higher in E. coli strains from DSS-treated than from control mice. Reporter experiments confirmed the induction of nfuA in response to iron deprivation, mimicking Fe-S cluster destruction by inflammation. YggE expression, which has been reported to reduce the intracellular level of reactive oxygen species, was 4- to 8-fold higher in E. coli Nissle than in E. coli UNC. This was confirmed by in vitro reporter gene assays indicating that Nissle is better equipped to cope with oxidative stress than UNC. Nissle isolated from DSS-treated and control mice had TnaA levels 4- to 7-fold-higher than those of UNC. Levels of indole resulting from the TnaA reaction were higher in control animals associated with E. coli Nissle. Because of its anti-inflammatory effect, indole is hypothesized to be involved in the extension of the remission phase in ulcerative colitis described for E. coli Nissle.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210207      PMCID: PMC3294480          DOI: 10.1128/AEM.07340-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  49 in total

1.  Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria.

Authors:  Martin L Cross; Anja Ganner; Diaa Teilab; Linley M Fray
Journal:  FEMS Immunol Med Microbiol       Date:  2004-10-01

Review 2.  Antimicrobial peptides of phagocytes and epithelia.

Authors:  T Ganz; J Weiss
Journal:  Semin Hematol       Date:  1997-10       Impact factor: 3.851

3.  Reversibility of the tryptophanase reaction: synthesis of tryptophan from indole, pyruvate, and ammonia.

Authors:  T Watanabe; E E Snell
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

4.  Lactoferrin in plasma measured by an ELISA technique: evidence that plasma lactoferrin is an indicator of neutrophil turnover and bone marrow activity in acute leukaemia.

Authors:  H S Birgens
Journal:  Scand J Haematol       Date:  1985-04

5.  alpha, beta-Dihydroxyisovalerate dehydratase. A superoxide-sensitive enzyme.

Authors:  C F Kuo; T Mashino; I Fridovich
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

6.  Construction and properties of a family of pACYC184-derived cloning vectors compatible with pBR322 and its derivatives.

Authors:  B Bartolomé; Y Jubete; E Martínez; F de la Cruz
Journal:  Gene       Date:  1991-06-15       Impact factor: 3.688

7.  Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.

Authors:  Lubomir Grozdanov; Carsten Raasch; Jürgen Schulze; Ulrich Sonnenborn; Gerhard Gottschalk; Jörg Hacker; Ulrich Dobrindt
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

8.  The inactivation of Fe-S cluster containing hydro-lyases by superoxide.

Authors:  D H Flint; J F Tuminello; M H Emptage
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

9.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

10.  An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice.

Authors:  M Schuppler; K Lötzsch; M Waidmann; I B Autenrieth
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more
  12 in total

Review 1.  Role of commensal gut bacteria in inflammatory bowel diseases.

Authors:  Gunnar Loh; Michael Blaut
Journal:  Gut Microbes       Date:  2012-10-11

Review 2.  No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens.

Authors:  Martina Sassone-Corsi; Manuela Raffatellu
Journal:  J Immunol       Date:  2015-05-01       Impact factor: 5.422

Review 3.  Microbiota in health and diseases.

Authors:  Kaijian Hou; Zhuo-Xun Wu; Xuan-Yu Chen; Jing-Quan Wang; Dongya Zhang; Chuanxing Xiao; Dan Zhu; Jagadish B Koya; Liuya Wei; Jilin Li; Zhe-Sheng Chen
Journal:  Signal Transduct Target Ther       Date:  2022-04-23

4.  Inflammation fuels colicin Ib-dependent competition of Salmonella serovar Typhimurium and E. coli in enterobacterial blooms.

Authors:  Lubov Petkova Nedialkova; Rémy Denzler; Martin B Koeppel; Manuel Diehl; Diana Ring; Thorsten Wille; Roman G Gerlach; Bärbel Stecher
Journal:  PLoS Pathog       Date:  2014-01-02       Impact factor: 6.823

Review 5.  Microbial imbalance and intestinal pathologies: connections and contributions.

Authors:  Ye Yang; Christian Jobin
Journal:  Dis Model Mech       Date:  2014-10       Impact factor: 5.758

Review 6.  How informative is the mouse for human gut microbiota research?

Authors:  Thi Loan Anh Nguyen; Sara Vieira-Silva; Adrian Liston; Jeroen Raes
Journal:  Dis Model Mech       Date:  2015-01       Impact factor: 5.758

7.  Colicin FY inhibits pathogenic Yersinia enterocolitica in mice.

Authors:  Juraj Bosák; Lenka Micenková; Matěj Hrala; Katarína Pomorská; Michaela Kunova Bosakova; Pavel Krejci; Eduard Göpfert; Martin Faldyna; David Šmajs
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

8.  A decrease in anaerobic bacteria promotes Candida glabrata overgrowth while β-glucan treatment restores the gut microbiota and attenuates colitis.

Authors:  Rogatien Charlet; Clovis Bortolus; Melissandre Barbet; Boualem Sendid; Samir Jawhara
Journal:  Gut Pathog       Date:  2018-12-03       Impact factor: 4.181

9.  Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.

Authors:  Harmit S Ranhotra; Kyle L Flannigan; Martina Brave; Subhajit Mukherjee; Dana J Lukin; Simon A Hirota; Sridhar Mani
Journal:  Nucl Receptor Res       Date:  2016

10.  Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn's disease.

Authors:  Gavin M Douglas; Richard Hansen; Casey M A Jones; Katherine A Dunn; André M Comeau; Joseph P Bielawski; Rachel Tayler; Emad M El-Omar; Richard K Russell; Georgina L Hold; Morgan G I Langille; Johan Van Limbergen
Journal:  Microbiome       Date:  2018-01-15       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.